Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Medicenna Therapeutics Corp (MDNA.TO)

Medicenna Therapeutics Corp (MDNA.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medicenna Therapeutics Corp 2 Bloor Street W. 7th Floor Toronto ON M4W 3E2 CAN

https://www.medicenna.com

Description:

Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL13 Superkines and Empowered Superkines for the treatment of cancer and other diseases. Its pipeline candidates include MDNA55 for recurrent glioblastoma multiforme (rGBM), MDNA11 for Cancer immunotherapies, MDNA209 for Autoimmune Diseases, MDNA413 for Cancer immunotherapies, and MDNA132 for Solid Tumors, BiSKITs represents the novel platform comprised of Bifunctional SuperKine ImmunoTherapies.

Key Statistics

Overview:

Market Capitalization, $K 184,203
Shares Outstanding, K 76,433
Annual Sales, $ 0 K
Annual Net Income, $ -25,466 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,637 K
60-Month Beta 3.29
% of Institutional Shareholders 0.40%

Growth:

1-Year Return 436.96%
3-Year Return -5.86%
5-Year Return 41.76%
5-Year Revenue Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.05 on 07/31/24
Next Earnings Date 11/12/24 [--]
Earnings Per Share ttm -0.38
EPS Growth vs. Prev Year 184.62%
Dividend Payout Ratio 0.00%
Most Recent Split 1-14 on 03/03/17

MDNA.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -105.43%
Return-on-Assets % -75.44%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book 8.05
Book Value/Share 0.30
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar